Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Zai Lab Ltd ADR (NQ: ZLAB ) 19.08 -0.31 (-1.59%) Streaming Delayed Price Updated: 11:46 AM EDT, Jul 24, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 117,949 Open 19.00 Bid (Size) 19.08 (1) Ask (Size) 19.22 (5) Prev. Close 19.39 Today's Range 18.79 - 19.38 52wk Range 13.48 - 32.60 Shares Outstanding 956,637,360 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Zai Lab and argenx Announce Approval of Efgartigimod Alfa Injection (Subcutaneous Injection) for Generalized Myasthenia Gravis in China July 16, 2024 From Zai Lab Limited Via Business Wire Zai Lab-Supported Study Published in Cell Provides New Insights with Potential to Improve Treatment of HRD-Positive Ovarian Cancers, Including Through Combination PARP Inhibitor and CCR8 Therapy July 15, 2024 From Zai Lab Limited Via Business Wire Performance YTD -26.78% -26.78% 1 Month +1.77% +1.77% 3 Month +26.20% +26.20% 6 Month -17.08% -17.08% 1 Year -37.81% -37.81% More News Read More Zai Lab to Announce Second Quarter 2024 Financial Results and Recent Corporate Updates on August 6, 2024 July 10, 2024 From Zai Lab Limited Via Business Wire Zai Lab Announces Dr. Harald Reinhart to Retire as Head of Global Development for Neuroscience, Autoimmune and Infectious Diseases; Dr. Rafael Amado to be Appointed President, Head of Global R&D June 11, 2024 From Zai Lab Limited Via Business Wire Why Core & Main Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session June 04, 2024 Via Benzinga Saia, Annexon, Core Scientific And Other Big Stocks Moving Higher On Tuesday June 04, 2024 Via Benzinga Zai Lab Initiates Global Phase 2 Clinical Trial Evaluating ZL-1102 As a Topical Treatment for Chronic Plaque Psoriasis May 22, 2024 From Zai Lab Limited Via Business Wire Zai Lab and Innoviva Specialty Therapeutics Announce NMPA Approval for XACDURO® (Sulbactam-Durlobactam or SUL-DUR) for Hospital-Acquired and Ventilator-Associated Pneumonia Caused by Acinetobacter Baumannii-Calcoaceticus Complex in China May 20, 2024 From Zai Lab Limited Via Business Wire Zai Lab Announces Participation in May and June Investor Conferences May 16, 2024 From Zai Lab Limited Via Business Wire Zai Lab Announces Acceptance of Supplemental Biologics License Application with Priority Review for Efgartigimod Alfa Injection (Subcutaneous Injection) in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in China May 14, 2024 From Zai Lab Limited Via Business Wire Zai Lab Announces Approval of AUGTYRO™ (repotrectinib) for Patients with ROS1-positive NSCLC by China’s NMPA May 12, 2024 From Zai Lab Limited Via Business Wire Why Duolingo Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Thursday's Mid-Day Session May 09, 2024 Via Benzinga 12 Health Care Stocks Moving In Thursday's Intraday Session May 09, 2024 Via Benzinga Fight Against Pancreatic Cancer Ramps Up as Market Size Revenues Expected to Exceed $36 Billion by 2036 May 09, 2024 Via FinancialNewsMedia Spectrum Brands Posts Upbeat Results, Joins AerSale, Sinclair, ICU Medical And Other Big Stocks Moving Higher On Thursday May 09, 2024 Via Benzinga Top 5 Health Care Stocks That Could Sink Your Portfolio In Q2 May 09, 2024 Via Benzinga 12 Health Care Stocks Moving In Thursday's Pre-Market Session May 09, 2024 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday May 09, 2024 Via InvestorPlace ZLAB Stock Earnings: Zai Lab Beats EPS, Beats Revenue for Q1 2024 May 08, 2024 Via InvestorPlace Zai Lab Announces First Quarter 2024 Financial Results and Recent Corporate Updates May 08, 2024 From Zai Lab Limited Via Business Wire Zai Lab to Announce First Quarter 2024 Financial Results and Recent Corporate Updates on May 8, 2024 April 15, 2024 From Zai Lab Limited Via Business Wire Zai Lab Statement on Executive Management Team’s Agreement on Share Activities April 11, 2024 From Zai Lab Limited Via Business Wire Week In Review: ProfoundBio, A Seattle-Suzhou ADC Biotech, Acquired By Genmab For $1.8 Billion April 06, 2024 Via Talk Markets Zai Lab Presentations at AACR 2024 Annual Meeting to Showcase Ongoing Clinical Studies in Key Global Oncology Programs April 02, 2024 From Zai Lab Limited Via Business Wire One Good, One Bad News For Bristol Myers Squibb's Marketed Drugs: Details April 01, 2024 Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
